文献速递肺栓塞与肺血管病

体外扩增外周血单核细胞移植通过CD14和CD163阳性M2巨噬细胞改善大鼠肺动脉高压

Transplantation of Ex Vivo Amplified Mononuclear Cells From Peripheral Blood Improves Rat Pulmonary Hypertension via CD14- and CD163-Positive M2 Macrophages.
PubMed 文献 · Respirology · 2026-02-04

本研究在大鼠肺动脉高压模型中,将体外扩增的外周血单核细胞(MNC-QQc)经颈静脉移植,发现其可逆转肺动脉高压引起的肺血流动力学异常和肺动脉重塑。供体来源的MNC-QQc细胞主要为CD14阳性M2巨噬细胞,聚集于受体肺动脉周围;去除M2细胞的MNC-QQc疗效减弱。MNC-QQc还促进肺内皮细胞血管生成,并通过CD14和CD163阳性M2巨噬细胞降低与PAH进展相关的Tachykinin Receptor 1表达。

要点

  • MNC-QQc移植可逆转大鼠PAH的肺血流动力学和肺动脉重塑。
  • 治疗效应主要由CD14和CD163阳性M2巨噬细胞介导。
  • MNC-QQc降低肺组织Tachykinin Receptor 1表达,可能为PAH新治疗策略。

核心结论

  • MNC-QQc移植可能通过CD14和CD163阳性M2巨噬细胞成为肺动脉高压的新型治疗方法。

研究设计与样本

  • 研究采用GFP阳性供体大鼠提取的MNC-QQc,经颈静脉移植给PAH受体大鼠,评估肺血流动力学和肺动脉重塑。

主要发现

  • MNC-QQc移植逆转了PAH诱导的肺血流动力学异常和肺动脉重塑。
  • GFP阳性MNC-QQc细胞主要为CD14阳性M2巨噬细胞,存在于受体肺动脉周围。
  • 去除M2细胞的MNC-QQc治疗效果减弱。
  • MNC-QQc增强肺内皮细胞血管生成。
  • 肺组织微阵列分析显示MNC-QQc降低Tachykinin Receptor 1表达,与CD14和CD163阳性M2巨噬细胞相关。

临床怎么用

  • MNC-QQc移植可能作为PAH的潜在细胞治疗方法,尤其通过CD14和CD163阳性M2巨噬细胞发挥作用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVE: The progression of pulmonary arterial hypertension (PAH) is associated with pulmonary artery (PA) remodelling by M2 macrophages through excessive tissue repair, although some M2 macrophages have a vascular protective role. A quality and quantity culture method (MNC-QQc) increases the number of M2 macrophages in mononuclear cells (MNCs) from peripheral blood. Several studies demonstrate that MNC-QQc has vascular protective effects in ischemic lesions. This study aimed to investigate whether MNC-QQc transplantation ameliorates PAH development in a rat model. METHODS: MNC-QQc extracted from GFP positive donor rats were administered into recipient rats with PAH via the cervical vein. Pulmonary haemodynamics and PA remodelling were assessed. Immunohistochemistry and flow cytometry analysis were performed to identify the donor-derived MNC-QQc cell types in the lungs. The effects of MNC-QQc on the functions of vascular constituent cells were evaluated, and gene expression related to the pathological abnormalities in PA was assessed using microarray analysis. RESULTS: MNC-QQc transplantation reversed the PAH-induced pulmonary haemodynamics and PA remodelling. GFP-positive MNC-QQc cells, predominantly CD14-positive M2 macrophages, were found around the recipient's PAs. The therapeutic effect was reduced in MNC-QQc without M2 cells. MNC-QQc also enhanced angiogenesis in pulmonary endothelial cells. Microarray analysis of the lung tissue showed that MNC-QQc decreased the expression of Tachykinin Receptor 1, associated with PAH progression, with this reduction linked to CD14- and CD163-positive M2 macrophages. CONCLUSIONS: These findings suggest that MNC-QQc, particularly through CD14- and CD163-positive M2 macrophages, could be a novel treatment for PAH.

来源:Respirology,查看原文。版权归原作者所有。

引用

  1. Suzuki Y, Nagaoka T, Nagata Y, et al. Transplantation of Ex Vivo Amplified Mononuclear Cells From Peripheral Blood Improves Rat Pulmonary Hypertension via CD14- and CD163-Positive M2 Macrophages. Respirology. 2026. PMID: 41640181. doi:10.1002/resp.70206

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。